Colvin OM - Search Results

1

Pharmacological purging of bone marrow with reference to autografting.

Santos GW, Colvin OM. Santos GW, et al. Among authors: colvin om. Clin Haematol. 1986 Feb;15(1):67-83. doi: 10.1016/s0308-2261(86)80006-6. Clin Haematol. 1986. PMID: 2421955 Review. No abstract available.

2

Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation.

Jones RJ, Zuehlsdorf M, Rowley SD, Hilton J, Santos GW, Sensenbrenner LL, Colvin OM. Jones RJ, et al. Among authors: colvin om. Blood. 1987 Nov;70(5):1490-4. Blood. 1987. PMID: 3311205 Free article.

3

CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow.

Rowley SD, Zuehlsdorf M, Braine HG, Colvin OM, Davis J, Jones RJ, Saral R, Sensenbrenner LL, Yeager A, Santos GW. Rowley SD, et al. Among authors: colvin om. Blood. 1987 Jul;70(1):271-5. Blood. 1987. PMID: 3297203 Free article.

4

Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.

Yeager AM, Kaizer H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH, et al. Yeager AM, et al. Among authors: colvin om. N Engl J Med. 1986 Jul 17;315(3):141-7. doi: 10.1056/NEJM198607173150301. N Engl J Med. 1986. PMID: 3523241 Clinical Trial.

5

Thalidomide for graft-versus-host disease.

Vogelsang GB, Santos GW, Colvin OM, Chen T. Vogelsang GB, et al. Among authors: colvin om. Lancet. 1988 Apr 9;1(8589):827. doi: 10.1016/s0140-6736(88)91690-x. Lancet. 1988. PMID: 2895345 Free article. No abstract available.

6

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation.

Grochow LB, Jones RJ, Brundrett RB, Braine HG, Chen TL, Saral R, Santos GW, Colvin OM. Grochow LB, et al. Among authors: colvin om. Cancer Chemother Pharmacol. 1989;25(1):55-61. doi: 10.1007/BF00694339. Cancer Chemother Pharmacol. 1989. PMID: 2591002

7

Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.

Chen TL, Vogelsang GB, Petty BG, Brundrett RB, Noe DA, Santos GW, Colvin OM. Chen TL, et al. Among authors: colvin om. Drug Metab Dispos. 1989 Jul-Aug;17(4):402-5. Drug Metab Dispos. 1989. PMID: 2571480

8

In vitro evaluation of combination drug purging for autologous bone marrow transplantation.

Jones RJ, Miller CB, Zehnbauer BA, Rowley SD, Colvin OM, Sensenbrenner LL. Jones RJ, et al. Among authors: colvin om. Bone Marrow Transplant. 1990 May;5(5):301-7. Bone Marrow Transplant. 1990. PMID: 2350626

9

In vitro synergism of 4-hydroperoxycyclophosphamide and cisplatin: relevance for bone marrow purging.

Peters RH, Brandon CS, Avila LA, Colvin OM, Stuart RK. Peters RH, et al. Among authors: colvin om. Cancer Chemother Pharmacol. 1989;23(3):129-34. doi: 10.1007/BF00267942. Cancer Chemother Pharmacol. 1989. PMID: 2924369

10

Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.

Rowley SD, Jones RJ, Piantadosi S, Braine HG, Colvin OM, Davis J, Saral R, Sharkis S, Wingard J, Yeager AM, et al. Rowley SD, et al. Among authors: colvin om. Blood. 1989 Jul;74(1):501-6. Blood. 1989. PMID: 2665843 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters